Cargando…
Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770
Autores principales: | Uldrick, TS, Mosam, A, Shaik, F, Friedland, G, Skadden, D, Jordaan, JP, Aboobaker, J, Coovadia, HM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261824/ http://dx.doi.org/10.1186/1750-9378-4-S2-P41 |
Ejemplares similares
-
The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and \chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa
por: Mosam, A, et al.
Publicado: (2010) -
Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)
por: Uldrick, TS, et al.
Publicado: (2009) -
HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial
por: Mosam, Anisa, et al.
Publicado: (2010) -
Health-Related Quality of Life in Patients Treated With
Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for
HIV-Associated Kaposi Sarcoma: A Randomized Control Trial
por: Shaik, Fahmida, et al.
Publicado: (2018) -
Scaling-Up Exclusive Breastfeeding Support Programmes: The Example of KwaZulu-Natal
por: Desmond, Chris, et al.
Publicado: (2008)